HTATIP2 and neoplasm: Since downregulation of HTATIP2 has been associated with acquired sorafenib resistance [28,29,30], a cytotoxicity study was carried out to examine the impact of HTATIP2 knockdown on tumor cell response to sorafenib treatment in vitro under normoxic and hypoxic conditions.